1. Home
  2. MSSA vs BYSI Comparison

MSSA vs BYSI Comparison

Compare MSSA & BYSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MSSA
  • BYSI
  • Stock Information
  • Founded
  • MSSA 2021
  • BYSI 2010
  • Country
  • MSSA United States
  • BYSI United States
  • Employees
  • MSSA N/A
  • BYSI N/A
  • Industry
  • MSSA
  • BYSI Biotechnology: Pharmaceutical Preparations
  • Sector
  • MSSA
  • BYSI Health Care
  • Exchange
  • MSSA NYSE
  • BYSI Nasdaq
  • Market Cap
  • MSSA 77.8M
  • BYSI 69.3M
  • IPO Year
  • MSSA 2022
  • BYSI 2017
  • Fundamental
  • Price
  • MSSA $11.80
  • BYSI $1.72
  • Analyst Decision
  • MSSA
  • BYSI
  • Analyst Count
  • MSSA 0
  • BYSI 0
  • Target Price
  • MSSA N/A
  • BYSI N/A
  • AVG Volume (30 Days)
  • MSSA 2.4K
  • BYSI 21.8K
  • Earning Date
  • MSSA 01-01-0001
  • BYSI 01-01-0001
  • Dividend Yield
  • MSSA N/A
  • BYSI N/A
  • EPS Growth
  • MSSA N/A
  • BYSI N/A
  • EPS
  • MSSA 0.19
  • BYSI N/A
  • Revenue
  • MSSA N/A
  • BYSI $1,876,000.00
  • Revenue This Year
  • MSSA N/A
  • BYSI N/A
  • Revenue Next Year
  • MSSA N/A
  • BYSI N/A
  • P/E Ratio
  • MSSA $62.20
  • BYSI N/A
  • Revenue Growth
  • MSSA N/A
  • BYSI 21.03
  • 52 Week Low
  • MSSA $10.94
  • BYSI $0.82
  • 52 Week High
  • MSSA $14.48
  • BYSI $4.00
  • Technical
  • Relative Strength Index (RSI)
  • MSSA 44.77
  • BYSI 52.47
  • Support Level
  • MSSA $11.50
  • BYSI $1.58
  • Resistance Level
  • MSSA $11.85
  • BYSI $1.75
  • Average True Range (ATR)
  • MSSA 0.48
  • BYSI 0.09
  • MACD
  • MSSA -0.07
  • BYSI 0.02
  • Stochastic Oscillator
  • MSSA 15.96
  • BYSI 74.07

About MSSA METAL SKY STAR ACQUISITION CORP

Metal Sky Star Acquisition Corp is a blank check company formed for the purpose of effecting a merger, share exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses.

About BYSI BeyondSpring Inc.

BeyondSpring Inc is engaged in clinical-stage biopharmaceutical activities focused on the development of cancer therapies. It is also focused on including immuno-oncology agents. It has two reportable segments Plinabulin pipeline and the TPD platform.

Share on Social Networks: